Galera’s Acquisition of Nova Pharmaceuticals Marks Major Shift to Combat Resistant Breast Cancer Galera Therapeutics, Inc. has officially completed its acquisition of Nova Pharmaceuticals, a biotechnology company focusing on treating resistant breast cancer with a pan-nitric oxide synthase (NOS) ...

www.linkedin.com/pulse/galera...

Galera’s Acquisition of Nova Pharmaceuticals Marks Major Shift to Combat Resistant Breast Cancer

kstrategyand.com/pharma-news

#GaleraTherapeutics #NovaPharmaceuticals #BreastCancerResearch #MetaplasticBreastCancer #InvestInCancer #Humanteconomy #Humantec